http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012145855-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
filingDate | 2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2012145855-A |
titleOfInvention | TRICYCLIC COMPOUNDS AND THEIR RVC INHIBITORS |
abstract | 1. The compound represented by general formula I, or a pharmaceutically acceptable salt thereof, in which each R, R, R and R independently is a group selected from the group consisting of: hydrogen, hydroxyl, halogen, cyano, nitro, amino, C-C1-6 alkyl -Calkenyl, C-Calkynyl, C-C-cycloalkyl, C-C-cycloalkenyl, C-Calkoxy, C-Caryl, indanyl, heteroaryl, 3-8 membered heterocycloalkyl, -OSOCH, -OSOCF, -CONH, -OCONRR, in which each R and R independently is hydrogen, C-C1-6 alkyl or R and R taken together form morpholinyl, -OCOR, in which R represents C-C1-6 alkyl, and-OCOOR, in which R represents C-C1-6 alkyl in which R, R, R and R are optionally substituted with a substituent independently selected from the group consisting of substituent A; wherein the substituent A is independently selected from the group consisting of hydroxy; oxo (= O); cyano; halogen; C- C 1-6 alkyl optionally substituted with substituent B; C 1-6 cycloalkyl optionally substituted with cyano or C 1-6 alkyl substituted with -NRR in which each R and R independently is hydrogen or C-C 1-6 alkyl; -NRR in which each R and R independently represents hydrogen; C 1-6 alkyl optionally substituted with hydroxyl, amino, di (C 1-6 alkyl) amino, -SO (C 1-6 alkyl), 3-8 membered heterocycloalkyl or cyano; or a 3-8 membered heterocycloalkyl optionally substituted with -COOR in which R is C-Calkyl; C-Calkoxy optionally substituted with halogen, a 3-8-membered heterocycloalkyl optionally substituted with C-Calkyl or -NRR in which each R and R are independently represents hydrogen, C 1 -C 6 alkylsulfonyl or C 1-6 alkyl optionally substituted with C 1-6 alkylsulfonyl or di (C 1-6 alkyl) amino; -SONRR in which each R and R are independently hydrogen; C-C1-6alkyl, optionally beyond |
priorityDate | 2010-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1319.